A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

Abroad (travel likely)RecruitingPHASE1

Conditions

Leukemia · Acute Myeloid Leukemia · Lymphoblastic Leukemia in Children

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Study coordinator (Rohith Jesudas, MBBS) · referralinfo@stjude.org · 866-278-5833

Study leads

Joshua Wolf, MBBS
Principal Investigator
St. Jude Children's Research Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

Leukemia · Inborn Errors of Metabolism · Bone Marrow Failure Syndromes

Abroad (travel likely)RecruitingEARLY_PHASE1

Philadelphia, United States

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia

Abroad (travel likely)Recruiting

Detroit, United States

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

Myeloma · Non-Hodgkin's Lymphoma · Leukemia

Abroad (travel likely)RecruitingPHASE2, PHASE3

Adelaide, Australia · Melbourne, Australia

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Acute Myeloid Leukemia, in Relapse · Acute Myeloid Leukemia Refractory

Abroad (travel likely)RecruitingPHASE1

Milwaukee, United States